Colpman David

Director David Colpman bought 12,500 shares of ELUT at $0.51; stock down 88.8% from 52-week high, company unprofitable with -$3.9M net income.

Colpman purchased 12,500 shares at $0.51 on 2025-12-17, increasing his holdings by 67.2% to 31,098 shares. The company faces significant fundamental headwinds: revenue of $3.3M declined 1.5% year-over-year, and the firm posted a net loss of $3.9M in its most recent fiscal year. The stock trades at $0.54, down 88.8% from its 52-week high of $4.84 and down 22.4% over the past 30 days. Notably, a cluster of 4 other insiders also purchased shares within the past 14 days, suggesting coordinated accumulation at depressed levels. However, Colpman's prior cross-ticker buy had a -31.8% average 30-day return, and his one prior purchase at this ticker also showed a -31.8% 30-day outcome, raising questions about the timing and conviction behind accumulation in a fundamentally challenged company at an already volatile price point.

Director Colpman buys 15,500 shares of ELUT at $0.74; holdings surge 500.3% while stock down 86.4% from 52-week high.

Director David Colpman purchased 15,500 shares at $0.74, increasing his holdings from 3,098 to 18,598 shares (+500.3% net change). The purchase occurred when ELUTIA INC. traded at $0.66 currently, down -86.4% from its 52-week high of $4.84 and -70.0% over the past 90 days. The company is unprofitable with a net income of -$3,868,000 in the latest quarter, annual revenue of $3,323,000, and a market capitalization of $428,128.14. The director's substantial accumulation at depressed price levels, combined with the company's negative earnings and steep share price erosion, warrants investor scrutiny into the motivations and outlook driving this concentrated position increase.